Cell compositions and methods for cancer therapy
US10344073B2 · kind B2 · utility
0Cited by
11References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2015 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Jan 8, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/998
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is directed to the field of immunotherapy. Specifically, provided are compositions and methods for improved T cell modulation ex vivo and in vivo and for the treatment of cancer and other pathologies. More specifically, embodiments of the subject matter are directed to the use of soluble NTB-A polypeptides or agonists thereof for the treatment of cancer patients, for preventing and treating cytopenia in susceptible patients, and for the ex vivo preparation of improved cell compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.